Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User - Global Forecasts to 2021

  • ID: 4031226
  • Report
  • Region: Global
  • 155 Pages
  • Markets and Markets
1 of 6
The Blood Screening Market is Expected to Reach USD 2.80 Billion By 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7%

FEATURED COMPANIES

  • Abbott Laboratories
  • BD
  • Beckman Coulter
  • Biomérieux
  • F. Hoffmann-La Roche
  • Grifols
  • MORE

The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The global blood screening market is categorized based on technology, product & service, end user, and region. The technology segment includes nucleic acid tests (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS).

The NAT segment is expected to grow at the highest CAGR during the forecast period. Major factors contributing to the growth in this segment are increasing number of blood donations, rising incidence of various infectious diseases, and increasing disposable income to pay for advanced blood screening procedures including NAT-test.

On the basis of product & service, the market is segmented into reagents & kits, instruments, and software & services. In 2016, the reagents and kits segment is expected to account for the largest share of the market. The repeated usage of reagents and kits is the key driving factor driving the growth of this segment.

On the basis of end user, the market is segmented into blood banks and hospitals. In 2016, the blood banks segment is expected to account for the largest of the market. This is primarily due to the increasing number of organ transplantation surgeries, increasing demand for donated blood, rising awareness regarding the safety of blood, and increasing number of donations worldwide.

Geographically, the blood screening market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growth of this market can be attributed to the increasing adoption of nucleic acid tests (NAT) in this region. In addition, the increasing participation of various government associations in blood donations and screening & transfusion activities also supports the growth of the North American blood screening market.

Globally, the blood screening market is witnessing substantial growth due to factors such as increasing number of blood donations and blood donors, growing affordability and adoption of nucleic acid test (NAT) for blood screening, rising awareness regarding the safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases.

The major players in this market include Grifols (Spain), Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Ortho Clinical Diagnostics, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), bioMérieux (France), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).

Research Coverage:
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the blood screening market.

Reasons to Buy the Report:

  • This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
  • The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the blood screening market. The report analyses the blood screening market by technology, product & service, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the blood screening market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the blood screening market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various blood screening products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the blood screening market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • BD
  • Beckman Coulter
  • Biomérieux
  • F. Hoffmann-La Roche
  • Grifols
  • MORE

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Assumptions For The Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Conclusion

4 Premium Insights
4.1 Blood Screening Market
4.2 Blood Screening Market, By Region & Technology

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number Of Blood Donations And Blood Donors
5.2.1.2 Increasing Demand Of Donated Blood
5.2.1.3 Rising Prevalence Of Infectious Diseases
5.2.1.4 Growing Affordability And Adoption Of Nat For Blood Screening
5.2.1.5 Rising Awareness About The Safety Of Donated Blood
5.2.2 Restraints
5.2.2.1 Capital Expenditure And Operating Costs Of Nat
5.2.2.2 Lack Of Regulations Mandating The Use Of Nat In Developing Countries
5.2.2.3 Emergence Of Alternative Technologies
5.2.3 Opportunities
5.2.3.1 Pathogen Reduction Technology
5.2.3.2 Multiplex Tests
5.2.3.3 Emerging Economies
5.2.4 Challenges
5.2.4.1 Price Reduction

6 Blood Screening Market, By Technology
6.1 Introduction
6.2 Blood Screening Market, By Volume (Number Of Tests Conducted)
6.3 Nat
6.3.1 Tma
6.3.2 Real-Time Polymerase Chain Reaction (Pcr)
6.4 Elisa
6.4.1 Elisa Market, By Platform
6.4.1.1 Clia
6.4.1.2 Fia
6.4.1.3 Ci
6.4.2 Elisa Market, By Generation
6.4.2.1 First-Generation Elisa
6.4.2.2 Second-Generation Elisa
6.4.2.3 Third-Generation Elisa
6.4.2.4 Fourth-Generation & Above
6.5 Rapid Tests
6.6 Western Blot Assay
6.7 Ngs

7 Blood Screening Market, By Product And Service
7.1 Introduction
7.2 Reagents & Kits
7.2.1 Nat Reagents & Kits
7.2.1.1 Enzymes And Polymerases
7.2.1.2 Standards And Controls
7.2.1.3 Probes And Primers
7.2.1.4 Buffers, Nucleotides, And Solutions
7.2.1.5 Labeling And Detection Reagents
7.2.2 Elisa Reagents & Kits
7.2.2.1 Immunosorbents
7.2.2.2 Controls
7.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
7.2.2.4 Substrates (Of Enzymes)
7.2.2.5 Sample Diluents And Wash Solutions
7.2.3 Other Reagents
7.3 Instruments
7.3.1 Rental Purchase
7.3.2 Outright Purchase
7.4 Software & Services

8 Blood Screening Market, By End User
8.1 Introduction
8.2 Blood Banks
8.3 Hospitals
9 Blood Screening Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Roe
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Roa
9.5 Row

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Market Share Analysis For Nat
10.2.2 Blood Screening Market Share Analysis
10.3 Competitive Situations And Trends
10.3.1 Product Launches
10.3.2 Regulatory Approvals
10.3.3 Agreements
10.3.4 Partnerships
10.3.5 Acquisitions
10.3.6 Expansions

11 Company Profiles
(Business Overview, Products Offered, Recent Developments, Mnm View)*
11.1 Introduction
11.2 Grifols
11.3 F. Hoffmann-La Roche
11.4 Abbott Laboratories
11.5 Biomérieux
11.6 Bio-Rad Laboratories, Inc.
11.7 Siemens Healthineers (A Subsidiary Of Siemens Ag)
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Thermo Fisher Scientific, Inc.
11.10 Beckman Coulter (A Subsidiary Of Danaher Corporation)
11.11 Bd
*Business Overview, Products Offered, Recent Developments, Mnm View Might Not Be Captured In Case Of Unlisted Companies.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Subscription Portal
12.3 Introducing Rt: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List Of Tables
Table 1 Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 2 Global Blood Screening Market, By Volume (Number Of Tests), 2015
Table 3 North America: Blood Screening Market, By Volume (Number Of Tests), 2015
Table 4 Europe: Blood Screening Market, By Volume (Number Of Tests), 2015
Table 5 Asia: Blood Screening Market, By Volume (Number Of Tests), 2015
Table 6 Blood Screening Market Size For Nat, By Country, 2014–2021 (Usd Million)
Table 7 Blood Screening Market Size For Nat, By Type, 2014–2021 (Usd Million)
Table 8 Tma Market Size, By Country, 2014–2021 (Usd Million)
Table 9 Real-Time Pcr Market Size, By Country, 2014–2021 (Usd Million)
Table 10 Blood Screening Market Size For Elisa, By Country, 2014–2021 (Usd Million)
Table 11 Blood Screening Market Size For Elisa, By Platform, 2014–2021 (Usd Million)
Table 12 Clia Market Size, By Country, 2014–2021 (Usd Million)
Table 13 Fia Market Size, By Country, 2014–2021 (Usd Million)
Table 14 Ci Market Size, By Country, 2014–2021 (Usd Million)
Table 15 Blood Screening Market Size For Elisa, By Generation, 2014-2021 (Usd Million)
Table 16 First-Generation Elisa Market Size, By Country, 2014–2021 (Usd Million)
Table 17 Second-Generation Elisa Market Size, By Country, 2014–2021 (Usd Million)
Table 18 Third-Generation Elisa Market Size, By Country, 2014–2021 (Usd Million)
Table 19 Fourth-Generation Elisa Market Size, By Country, 2014–2021 (Usd Million)
Table 20 Blood Screening Market Size For Rapid Tests, By Country, 2014–2021 (Usd Million)
Table 21 Blood Screening Market Size For Western Blot Assay, By Country, 2014–2021 (Usd Million)
Table 22 Blood Screening Market Size For Ngs, By Country, 2014–2021 (Usd Million)
Table 23 Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 24 Blood Screening Reagents & Kits Market Size, By Country, 2014–2021 (Usd Million)
Table 25 Blood Screening Reagents & Kits Market Size, By Type, 2014–2021 (Usd Million)
Table 26 Nat Reagents & Kits Market Size, By Country, 2014–2021 (Usd Million)
Table 27 Nat Reagents & Kits Market Size, By Type, 2014–2021 (Usd Million)
Table 28 Elisa Reagents & Kits Market Size, By Country, 2014–2021 (Usd Million)
Table 29 Elisa Reagents & Kits Market Size, By Type, 2014–2021 (Usd Million)
Table 30 Other Reagents & Kits Market Size, By Country, 2014–2021 (Usd Million)
Table 31 Blood Screening Instruments Market Size, By Country, 2014–2021 (Usd Million)
Table 32 Blood Screening Instruments Market Size, By Purchase Mode, 2014–2021 (Usd Million)
Table 33 Rental Purchase Market Size, By Country, 2014–2021 (Usd Million)
Table 34 Outright Purchase Market Size, By Country, 2014–2021 (Usd Million)
Table 35 Blood Screening Software & Services Market Size, By Country, 2014–2021 (Usd Million)
Table 36 Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 37 Blood Screening Market Size For Blood Banks, By Country, 2014–2021 (Usd Million)
Table 38 Blood Screening Market Size For Hospitals, By Country, 2014–2021 (Usd Million)
Table 39 Global Blood Screening Market Size, By Region, 2012–2019 (Usd Million)
Table 40 North America: Blood Screening Market Size, By Country, 2014-2021 (Usd Million)
Table 41 North America: Blood Screening Market Size, By Technology, 2014-2021 (Usd Million)
Table 42 North America: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 43 North America: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 44 Number Of Organ Transplantations Performed In The U.S., 2014-2015
Table 45 U.S.: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 46 U.S.: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 47 U.S.: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 48 Canada: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 49 Canada: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 50 Canada: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 51 Europe: Blood Screening Market Size, By Country, 2014–2021 (Usd Million)
Table 52 Europe: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 53 Europe: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 54 Europe: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 55 Germany: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 56 Germany: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 57 Germany: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 58 France: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 59 France: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 60 France: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 61 U.K.: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 62 U.K.: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 63 U.K.: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 64 Italy: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 65 Italy: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 66 Italy: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 67 Spain: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 68 Spain: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 69 Spain: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 70 Roe: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 71 Roe: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 72 Roe: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 73 Asia: Blood Screening Market Size, By Country, 2014–2021 (Usd Million)
Table 74 Asia: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 75 Asia: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 76 Asia: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 77 Japan: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 78 Japan: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 79 Japan: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 80 China: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 81 China: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 82 China: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 83 India: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 84 India: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 85 India: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 86 Roa: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 87 Roa: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 88 Roa: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 89 Row: Blood Screening Market Size, By Technology, 2014–2021 (Usd Million)
Table 90 Row: Blood Screening Market Size, By Product And Service, 2014–2021 (Usd Million)
Table 91 Row: Blood Screening Market Size, By End User, 2014–2021 (Usd Million)
Table 92 Product Launches, 2013-2016
Table 93 Regulatory Approvals, 2013-2016
Table 94 Agreements, 2013–2016
Table 95 Partnerships, 2013–2016
Table 96 Acquisitions, 2013–2016
Table 97 Expansions, 2013–2016

List Of Figures
Figure 1 Research Design
Figure 2 Blood Screening Market: Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Blood Screening Market Size, By Product And Service, 2016 Vs. 2021 (Usd Billion)
Figure 6 Blood Screening Market Size, By Technology, 2016 Vs. 2021 (Usd Billion)
Figure 7 Blood Screening Market Size, By End User, 2016 Vs. 2021 (Usd Billion)
Figure 8 North America Accounted For The Highest Share Of The Blood Screening Market In 2016
Figure 9 Blood Screening Market Is Expected To Offer Lucrative Growth Opportunities In The Forecast Period
Figure 10 Nat Segment Is Expected To Account For The Largest Market Share In 2016
Figure 11 Asia Is Expected To Grow At The Highest Cagr During The Forecast Period
Figure 12 Global Incidence Of Cancer
Figure 13 Nat Testing Will Continue To Dominate The Market During The Forecast Period
Figure 14 Reagents & Kits Segment Is Expected To Hold The Largest Share Of The Market During The Forecast Period
Figure 15 Blood Banks Segment Will Continue To Dominate The Blood Screening Market During The Forecast Period
Figure 16 Emerging Markets Offer Significant Growth Opportunities
Figure 17 Asian Blood Screening Market Is Expected To Grow At The Highest Cagr During The Forecast Period
Figure 18 North America: Market Snapshot
Figure 19 Reagents & Kits Segment To Hold Largest Share In The U.S. Market
Figure 20 Europe: Market Snapshot
Figure 21 Germany: Blood Screening Market, By Product And Service
Figure 22 Asia: Blood Screening Market Snapshot
Figure 23 Elisa Segment Is Expected To Grow At The Highest Cagr In The Japanese Market During 2016–2021
Figure 24 Blood Banks End-User Segment Is Expected To Continue To Dominate The Indian Blood Screening Market Until 2021
Figure 25 Row: Market Snapshot
Figure 26 Product Launches Was The Key Strategy Adopted By Leading Players
Figure 27 Nat Blood Screening Market Share Analysis, By Key Player, 2015
Figure 28 Blood Screening Market Share Analysis, By Key Company, 2015
Figure 29 Battle For Market Share: Product Launches, Partnerships And Agreements, The Key Growth Strategies Adopted Between 2014 And 2016
Figure 30 Product Benchmarking Of The Top Five Players
Figure 31 Grifols: Company Snapshot
Figure 32 F. Hoffmann-La Roche Ltd: Company Snapshot
Figure 33 Abbott Laboratories: Company Snapshot
Figure 34 Biomérieux: Company Snapshot
Figure 35 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 36 Siemens Ag: Company Snapshot
Figure 37 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 38 Danaher Corporation: Company Snapshot
Figure 39 Bd: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abbott Laboratories
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories, Inc.
  • Biomérieux
  • F. Hoffmann-La Roche
  • Grifols
  • Ortho Clinical Diagnostics, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll